Global Ocular Implant Market: Restraint
The major factors that hinder growth of the global ocular implant market include stringent regulatory approvals combined with recent product recalls. For instance, in August 2018, Alcon, an ophthalmology company, had to initiate voluntary product recall of Cypass Micro-Stent device, indicated for glaucoma surgery. This was attributed to complications in endothelial loss during the use of the device.
Increasing number of product launches are expected to drive growth of the global ocular implant market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients